• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性粒细胞白血病中Bcr-Abl癌蛋白亚型结构元件的差异

Differences in structural elements of Bcr-Abl oncoprotein isoforms in Chronic Myelogenous Leukemia.

作者信息

Hai Abdul, Kizilbash Nadeem A, Zaidi Syeda Huma H, Alruwaili Jamal, Shahzad Khuram

机构信息

Department of Biochemistry, Faculty of Medicine & Applied Medical Sciences, Northern Border University.

Department of Chemistry, Faculty of Science, Northern Border University, P.O. Box 1321, Arar-91431, Saudi Arabia.

出版信息

Bioinformation. 2014 Mar 19;10(3):108-14. doi: 10.6026/97320630010108. eCollection 2014.

DOI:10.6026/97320630010108
PMID:24748748
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3974235/
Abstract

in silico modeling, using Psipred and ExPASy servers was employed to determine the structural elements of Bcr-Abl oncoprotein (p210(BCR-ABL)) isoforms, b2a2 and b3a2, expressed in Chronic Myelogenous Leukemia (CML). Both these proteins are tyrosine kinases having masses of 210-kDa and differing only by 25 amino acids coded by the b3 exonand an amino acidsubstitution (Glu903Asp). The secondary structure elements of the two proteins show differences in five α-helices and nine β-strands which relates to differences in the SH3, SH2, SH1 and DNA-binding domains. These differences can result in different roles played by the two isoforms in mediating signal transduction during the course of CML.

摘要

利用Psipred和ExPASy服务器进行计算机模拟,以确定慢性粒细胞白血病(CML)中表达的Bcr-Abl癌蛋白(p210(BCR-ABL))亚型b2a2和b3a2的结构元件。这两种蛋白质都是酪氨酸激酶,质量为210 kDa,仅在由b3外显子编码的25个氨基酸和一个氨基酸取代(Glu903Asp)上有所不同。这两种蛋白质的二级结构元件在五个α螺旋和九个β链上存在差异,这与SH3、SH2、SH1和DNA结合域的差异有关。这些差异可能导致这两种亚型在CML病程中介导信号转导时发挥不同作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a477/3974235/755771fcfdc3/97320630010108F3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a477/3974235/f2038bec53e3/97320630010108F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a477/3974235/95f77e2b1764/97320630010108F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a477/3974235/755771fcfdc3/97320630010108F3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a477/3974235/f2038bec53e3/97320630010108F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a477/3974235/95f77e2b1764/97320630010108F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a477/3974235/755771fcfdc3/97320630010108F3.jpg

相似文献

1
Differences in structural elements of Bcr-Abl oncoprotein isoforms in Chronic Myelogenous Leukemia.慢性粒细胞白血病中Bcr-Abl癌蛋白亚型结构元件的差异
Bioinformation. 2014 Mar 19;10(3):108-14. doi: 10.6026/97320630010108. eCollection 2014.
2
The possible influences of B2A2 and B3A2 BCR/ABL protein structure on thrombopoiesis in chronic myeloid leukaemia.B2A2和B3A2 BCR/ABL蛋白结构对慢性髓性白血病血小板生成的可能影响。
Eur J Cancer. 2000 Jul;36(11):1395-401. doi: 10.1016/s0959-8049(00)00128-3.
3
Inhibition of chronic myelogenous leukemia cells harboring a BCR-ABL B3A2 junction by antisense oligonucleotides targeted at the B2A2 junction.通过靶向B2A2连接区的反义寡核苷酸抑制携带BCR-ABL B3A2连接区的慢性粒细胞白血病细胞。
Exp Hematol. 1995 Dec;23(14):1606-11.
4
Leukemogenesis of b2a2-type p210 BCR/ABL in a bone marrow transplantation mouse model using a lentiviral vector.使用慢病毒载体的骨髓移植小鼠模型中b2a2型p210 BCR/ABL的白血病发生
J Nippon Med Sch. 2009 Jun;76(3):134-47. doi: 10.1272/jnms.76.134.
5
Association of BCR/ABL transcript variants with different blood parameters and demographic features in Iraqi chronic myeloid leukemia patients.伊拉克慢性髓性白血病患者中 BCR/ABL 转录变体与不同血液参数和人口统计学特征的关联。
Mol Genet Genomic Med. 2019 Aug;7(8):e809. doi: 10.1002/mgg3.809. Epub 2019 Jun 17.
6
BCR-ABL Gene Transcript Types of Patients with Chronic Myelogenous Leukemia in Yogyakarta, Indonesia.印度尼西亚日惹市慢性髓性白血病患者的 BCR-ABL 基因转录类型。
Asian Pac J Cancer Prev. 2020 Jun 1;21(6):1545-1550. doi: 10.31557/APJCP.2020.21.6.1545.
7
A novel SH2-containing phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase (SHIP2) is constitutively tyrosine phosphorylated and associated with src homologous and collagen gene (SHC) in chronic myelogenous leukemia progenitor cells.一种新型的含SH2结构域的磷脂酰肌醇3,4,5-三磷酸5-磷酸酶(SHIP2)在慢性粒细胞白血病祖细胞中持续发生酪氨酸磷酸化,并与src同源和胶原蛋白基因(SHC)相关联。
Blood. 1999 Apr 15;93(8):2707-20.
8
Pre-B acute lymphoblastic leukemia with b3a2 (p210) and e1a2 (p190) BCR-ABL fusion transcripts relapsing as chronic myelogenous leukemia with a less differentiated b3a2 (p210) clone.伴有b3a2(p210)和e1a2(p190)BCR-ABL融合转录本的前体B淋巴细胞白血病复发为慢性粒细胞白血病,伴有分化程度较低的b3a2(p210)克隆。
Leukemia. 1999 Dec;13(12):2007-11. doi: 10.1038/sj.leu.2401598.
9
BCR/ABL p210, p190 and p230 fusion genes in 250 Mexican patients with chronic myeloid leukaemia (CML).250名墨西哥慢性髓性白血病(CML)患者中的BCR/ABL p210、p190和p230融合基因
Clin Lab Haematol. 2002 Jun;24(3):145-50. doi: 10.1046/j.1365-2257.2002.00413.x.
10
Frequency of BCR-ABL fusion transcripts in Sudanese patients with chronic myeloid leukemia using real-time reverse transcription-polymerase chain reaction.采用实时逆转录聚合酶链反应检测苏丹慢性髓性白血病患者中BCR-ABL融合转录本的频率
Saudi Med J. 2013 Jan;34(1):29-33.

引用本文的文献

1
Research on the functions and potential mechanisms of STAT3 in chronic myelogenous leukemia.信号转导与转录激活因子3(STAT3)在慢性粒细胞白血病中的功能及潜在机制研究
Discov Oncol. 2025 May 12;16(1):739. doi: 10.1007/s12672-025-02492-5.
2
Current and future of targeted therapies against BCR::ABL kinases.针对BCR::ABL激酶的靶向治疗的现状与未来。
J Egypt Natl Canc Inst. 2025 Apr 7;37(1):12. doi: 10.1186/s43046-025-00263-5.
3
Targeted Investigational Oncology Agents in the NCI-60: A Phenotypic Systems-based Resource.NCI-60 中的靶向肿瘤学研究药物:基于表型系统的资源。

本文引用的文献

1
Signaling networks associated with BCR-ABL-dependent transformation.与BCR-ABL依赖性转化相关的信号网络。
Cancer Control. 2009 Apr;16(2):100-7. doi: 10.1177/107327480901600202.
2
Chronic myeloid leukemia--advances in biology and new approaches to treatment.慢性髓性白血病——生物学进展与新的治疗方法
N Engl J Med. 2003 Oct 9;349(15):1451-64. doi: 10.1056/NEJMra020777.
3
ExPASy: The proteomics server for in-depth protein knowledge and analysis.ExPASy:用于深入蛋白质知识和分析的蛋白质组学服务器。
Mol Cancer Ther. 2023 Nov 1;22(11):1270-1279. doi: 10.1158/1535-7163.MCT-23-0267.
4
Comparison of molecular responses and outcomes between BCR::ABL1 e14a2 and e13a2 transcripts in chronic myeloid leukemia.慢性髓性白血病中 BCR::ABL1 e14a2 和 e13a2 转录本的分子反应和结果比较。
Cancer Sci. 2022 Oct;113(10):3518-3527. doi: 10.1111/cas.15501. Epub 2022 Aug 17.
5
Clinicopathological Variables and Outcome in Chronic Myeloid Leukemia Associated With BCR-ABL1 Transcript Type and Body Weight: An Outcome of European LeukemiaNet Project.与 BCR-ABL1 转录本类型和体重相关的慢性髓性白血病的临床病理变量和结局:欧洲白血病网项目的一项结果。
Cancer Control. 2021 Jan-Dec;28:10732748211038429. doi: 10.1177/10732748211038429.
6
Distribution of Transcript Variants in Nigerians with Chronic Myeloid Leukemia.慢性粒细胞白血病尼日利亚患者中转录本变体的分布情况
Indian J Hematol Blood Transfus. 2020 Oct;36(4):646-651. doi: 10.1007/s12288-020-01264-1. Epub 2020 Feb 25.
7
Prognostic Significance of Transcript-Type in Chronic Myeloid Leukemia.转录本类型在慢性髓性白血病中的预后意义
Mediterr J Hematol Infect Dis. 2020 Sep 1;12(1):e2020062. doi: 10.4084/MJHID.2020.062. eCollection 2020.
8
Influence of major transcript subtype on outcome in patients with chronic myeloid leukemia in chronic phase treated frontline with nilotinib.主要转录本亚型对一线使用尼洛替尼治疗的慢性期慢性髓性白血病患者预后的影响。
Oncotarget. 2020 Jun 30;11(26):2560-2570. doi: 10.18632/oncotarget.27652.
9
Does BCR-ABL transcript type influence the prognosis of patients in chronic myelogenous leukemia chronic phase?BCR-ABL转录本类型是否影响慢性粒细胞白血病慢性期患者的预后?
Hematol Transfus Cell Ther. 2019 Apr-Jun;41(2):114-118. doi: 10.1016/j.htct.2018.10.003. Epub 2019 Feb 16.
10
Response to Imatinib therapy is inferior for e13a2 transcript type in comparison to e14a2 transcript type in chronic myeloid leukaemia.在慢性髓性白血病中,与e14a2转录本类型相比,伊马替尼治疗对e13a2转录本类型的反应较差。
BMC Hematol. 2019 May 2;19:7. doi: 10.1186/s12878-019-0139-2. eCollection 2019.
Nucleic Acids Res. 2003 Jul 1;31(13):3784-8. doi: 10.1093/nar/gkg563.
4
Abl interactor 1 promotes tyrosine 296 phosphorylation of mammalian enabled (Mena) by c-Abl kinase.Abl相互作用蛋白1通过c-Abl激酶促进哺乳动物 Enabled(Mena)的酪氨酸296磷酸化。
J Biol Chem. 2003 Jun 13;278(24):21685-92. doi: 10.1074/jbc.M301447200. Epub 2003 Apr 2.
5
Structure of the Bcr-Abl oncoprotein oligomerization domain.Bcr-Abl癌蛋白寡聚化结构域的结构。
Nat Struct Biol. 2002 Feb;9(2):117-20. doi: 10.1038/nsb747.
6
The possible influences of B2A2 and B3A2 BCR/ABL protein structure on thrombopoiesis in chronic myeloid leukaemia.B2A2和B3A2 BCR/ABL蛋白结构对慢性髓性白血病血小板生成的可能影响。
Eur J Cancer. 2000 Jul;36(11):1395-401. doi: 10.1016/s0959-8049(00)00128-3.
7
The PSIPRED protein structure prediction server.PSIPRED蛋白质结构预测服务器。
Bioinformatics. 2000 Apr;16(4):404-5. doi: 10.1093/bioinformatics/16.4.404.
8
The biology of chronic myeloid leukemia.慢性髓性白血病的生物学
N Engl J Med. 1999 Jul 15;341(3):164-72. doi: 10.1056/NEJM199907153410306.
9
Structure and mutagenesis of the Dbl homology domain.Dbl同源结构域的结构与诱变
Nat Struct Biol. 1998 Dec;5(12):1098-107. doi: 10.1038/4209.
10
Stem cell kinetics.干细胞动力学
Baillieres Clin Haematol. 1997 Jun;10(2):233-57. doi: 10.1016/s0950-3536(97)80005-4.